Transcription Factors Drive Tet2-Mediated Enhancer Demethylation to Reprogram Cell Fate.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30220521.
- Also identified by DOI 10.1016/j.stem.2018.08.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Here, we report DNA methylation and hydroxymethylation dynamics at nucleotide resolution using C/EBPα-enhanced reprogramming of B cells into induced pluripotent cells (iPSCs). We observed successive waves of hydroxymethylation at enhancers, concomitant with a decrease in DNA methylation, suggesting active demethylation. Consistent with this finding, ablation of the DNA demethylase Tet2 almost completely abolishes reprogramming. C/EBPα, Klf4, and Tfcp2l1 each interact with Tet2 and recruit the enzyme to specific DNA sites. During reprogramming, some of these sites maintain high levels of 5hmC, and enhancers and promoters of key pluripotency factors become demethylated as early as 1 day after Yamanaka factor induction. Surprisingly, methylation changes precede chromatin opening in distinct chromatin regions, including Klf4 bound sites, revealing a pioneer factor activity associated with alternation in DNA methylation. Rapid changes in hydroxymethylation similar to those in B cells were also observed during compound-accelerated reprogramming of fibroblasts into iPSCs, highlighting the generality of our observations.
Medical subject headings
- Cellular Reprogramming
- DNA Methylation
- DNA-Binding Proteins
- Enhancer Elements, Genetic
- Induced Pluripotent Stem Cells
- Proto-Oncogene Proteins
- Transcription Factors